These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 16856912)

  • 1. Absence of the mutation of serine/threonine kinase genes AKT2 and MYLK2 in acute leukemias.
    Soung YH; Lee JW; Kim SY; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    Eur J Haematol; 2006 Aug; 77(2):175-6. PubMed ID: 16856912
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutational analysis of the kinase domain of MYLK2 gene in common human cancers.
    Soung YH; Lee JW; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Pathol Res Pract; 2006; 202(3):137-40. PubMed ID: 16448786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of pro-apoptotic ENDOG gene in common solid cancers and acute leukaemias.
    Kim MS; Yoo NJ; Lee SH
    Pathology; 2010 Dec; 42(7):696-7. PubMed ID: 21080888
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.
    Kim MS; Chung NG; Yoo NJ; Lee SH
    Leuk Res; 2011 Jun; 35(6):e87-8. PubMed ID: 21329978
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
    Kim MS; Jeong EG; Yoo NJ; Lee SH
    Br J Cancer; 2008 May; 98(9):1533-5. PubMed ID: 18392055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of MYC in common epithelial cancers and acute leukemias.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    APMIS; 2006 Jun; 114(6):436-9. PubMed ID: 16856965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of PRDM1 exon 2 mutation in acute leukemia.
    Yoo NJ; Jeong EG; Lee SH; Lee SH
    Eur J Haematol; 2007 Feb; 78(2):171-2. PubMed ID: 17328719
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival.
    Barata JT
    Adv Enzyme Regul; 2011; 51(1):37-49. PubMed ID: 21035501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of PDPK1 kinase domain in gastric, colorectal and lung carcinomas.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Acta Oncol; 2006; 45(3):340-1. PubMed ID: 16644580
    [No Abstract]   [Full Text] [Related]  

  • 10. No mutation in the FOXP3 gene in acute leukemias.
    Kim MS; Chung NG; Yoo NJ; Lee SH
    Leuk Res; 2011 Jan; 35(1):e10. PubMed ID: 20933283
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity, phosphorylation state and subcellular distribution of GLUT4-targeted Akt2 in rat adipose cells.
    Chen X; Al-Hasani H; Olausson T; Wenthzel AM; Smith U; Cushman SW
    J Cell Sci; 2003 Sep; 116(Pt 17):3511-8. PubMed ID: 12876218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of PRKD1 Mutation, a Salivary Tumor-Specific Mutation, in Solid Tumors and Leukemias.
    Jo YS; Kim MS; Yoo NJ; Lee SH
    Pathol Oncol Res; 2016 Jan; 22(1):231-2. PubMed ID: 26518775
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of oncogenic AKT1 E17K mutation in prostate, esophageal, laryngeal and urothelial carcinomas, hepatoblastomas, gastrointestinal stromal tumors and malignant meningiomas.
    Eom HS; Kim MS; Hur SY; Yoo NJ; Lee SH
    Acta Oncol; 2009; 48(7):1084-5. PubMed ID: 19353338
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatic mutation of proapoptotic caspase-2 gene is rare in acute leukemias and common solid cancers.
    Kim MS; Chung NG; Yoo NJ; Lee SH
    Eur J Haematol; 2011 May; 86(5):449-50. PubMed ID: 21332795
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutational analysis of RUNX1T1 gene in acute leukemias, breast and lung carcinomas.
    Kim YR; Kim MS; Lee SH; Yoo NJ
    Leuk Res; 2011 Sep; 35(9):e157-8. PubMed ID: 21571369
    [No Abstract]   [Full Text] [Related]  

  • 16. The JAK2 V617F mutation in de novo acute myelogenous leukemias.
    Lee JW; Kim YG; Soung YH; Han KJ; Kim SY; Rhim HS; Min WS; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Oncogene; 2006 Mar; 25(9):1434-6. PubMed ID: 16247455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
    Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the ARAF gene in human cancers.
    Lee JW; Soung YH; Kim SY; Park WS; Nam SW; Min WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2005 Jan; 113(1):54-7. PubMed ID: 15676015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-kit mutation screening in patients with acute myeloid leukaemia: adaptation of a Giemsa-stained bone-marrow smear DNA extraction technique.
    Court EL; Davidson K; Smith MA; Inman L; Marriott SA; Smith JG; Pallister CJ
    Br J Biomed Sci; 2001; 58(2):76-84. PubMed ID: 11440210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications.
    Bellacosa A; Franke TF; Gonzalez-Portal ME; Datta K; Taguchi T; Gardner J; Cheng JQ; Testa JR; Tsichlis PN
    Oncogene; 1993 Mar; 8(3):745-54. PubMed ID: 8437858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.